Stock Yards Bank & Trust Co. trimmed its position in Danaher Corporation (NYSE:DHR – Free Report) by 17.9% during the second quarter, HoldingsChannel.com reports. The fund owned 42,301 shares of the conglomerate’s stock after selling 9,233 shares during the quarter. Stock Yards Bank & Trust Co.’s holdings in Danaher were worth $8,356,000 at the end of the most recent reporting period.
A number of other hedge funds have also added to or reduced their stakes in the company. GHP Investment Advisors Inc. grew its stake in shares of Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock worth $25,000 after buying an additional 99 shares during the last quarter. Sierra Ocean LLC grew its stake in shares of Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock worth $29,000 after buying an additional 76 shares during the last quarter. Smallwood Wealth Investment Management LLC bought a new stake in shares of Danaher during the first quarter worth $31,000. Dunhill Financial LLC grew its stake in shares of Danaher by 68.4% during the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock worth $34,000 after buying an additional 67 shares during the last quarter. Finally, Costello Asset Management INC bought a new stake in shares of Danaher during the first quarter worth $41,000. 79.05% of the stock is owned by institutional investors.
Insider Buying and Selling at Danaher
In other news, Director Teri List sold 2,778 shares of the company’s stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 11.10% of the company’s stock.
Wall Street Analysts Forecast Growth
Check Out Our Latest Research Report on Danaher
Danaher Price Performance
DHR stock opened at $215.05 on Friday. The firm has a market cap of $153.98 billion, a price-to-earnings ratio of 45.75, a PEG ratio of 3.00 and a beta of 0.77. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $279.41. The company’s fifty day simple moving average is $200.19 and its 200 day simple moving average is $197.42.
Danaher (NYSE:DHR – Get Free Report) last released its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.16. The business had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. Danaher’s revenue for the quarter was up 3.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.
Danaher Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a $0.32 dividend. The ex-dividend date is Friday, September 26th. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s payout ratio is presently 27.23%.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
See Also
- Five stocks we like better than Danaher
- 3 Fintech Stocks With Good 2021 Prospects
- After Trump Deal, Can Meta Stock Withstand TikTok’s Onslaught?
- How to trade using analyst ratings
- Alphabet: After Its Best Quarter in Decades, Is It Time to Buy?
- How to Calculate Options Profits
- Forget Airlines—These Trucking Stocks Are Shifting Into High Gear
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.